Drugs / Anyu Peibo
Trials 3
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 22 trials | ||||||
| Phase 2 | NCT03183505 | Jun 2017 → Oct 2018 | major depressive disorder | Shanghai Mental Health Center | Completed | No outcome recorded |
| Phase 2 | NCT02380066 | Mar 2015 → Mar 2016 | major depressive disorder | Shanghai Mental Health Center | Completed | No outcome recorded |
| Phase 31 trial | ||||||
| Phase 3 | NCT04210973 | Jan → Dec 2020 | major depressive disorder | Shanghai Mental Health Center | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 3 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Anyu Peibo | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03183505 ↗ |
| Known as | Anyu Peibo Capsule | “Anyu Peibo Capsule” NCT03183505 ↗ |
| Route | Oral | “Anyu Peibo Capsule, oral, 0.2g twice per day” NCT02380066 ↗ |